Journal
BIOCHEMICAL PHARMACOLOGY
Volume 74, Issue 8, Pages 1283-1291Publisher
PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.bcp.2007.07.034
Keywords
acetylcholine; dopamine; glutamate; GABA; synaptic transmission; nicotinic
Categories
Funding
- NIDA NIH HHS [R01 DA015918-02, DA07255, R01 DA015918-05, R01 DA015918-03, T32 DA007255, R01 DA015918, P01 DA019695, DA015918, DA019695, R01 DA015918-04, T32 DA007255-15, R01 DA015918-01, P01 DA019695-01A2, T32 DA007255-14] Funding Source: Medline
- NINDS NIH HHS [R01 NS035090-03] Funding Source: Medline
Ask authors/readers for more resources
Each year, tobacco use causes over 4 million deaths worldwide and billions of dollars are spent on treatment for tobacco-related illness. Bupropion, an atypical antidepressant, improves the rates of successful smoking cessation, however, the mechanisms by which bupropion reduces cigarette smoking and depression are unknown, Here we show that clinical concentrations of bupropion inhibit nicotine's stimulatory effects on brain reward areas. Many drugs of abuse, including nicotine, stimulate dopamine (DA) release in the mesoaccumbens reward system. Nicotinic acetylcholine receptors in the ventral tegmental area (VTA) mediate nicotine's stimulation of DA release, as well as its rewarding effects. Nicotinic receptors are expressed by excitatory and inhibitory neurons that control DA neuron excitability, and by the DA neurons themselves. Bupropion is a broad-spectrum noncompetitive nicotinic receptor antagonist. Here we report that pre-treatment of brain slices with a clinically relevant concentration of bupropion dramatically reduces the effects of nicotine on DA neuron excitability. Nicotinic receptors on VTA DA neurons and their synaptic inputs are inhibited by 75-95% after bupropion treatment. We also find that bupropion alone reduces GABAergic transmission to DA neurons, thereby diminishing tonic inhibition of these neurons. This increases DA neuron excitability during bupropion treatment in the absence of nicotine, and may contribute to bupropion's antidepressant actions. (C) 2007 Elsevier Inc. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available